Skip to content

Foot and Ankle Clinic Application for Liposomal Related Anesthetic

Foot and Ankle Clinic Application for Liposomal Related Anesthetic

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02586077
Enrollment
36
Registered
2015-10-26
Start date
2014-02-01
Completion date
2016-11-15
Last updated
2020-10-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ankle Arthrodesis, Hindfoot Arthrodesis, Tibitalocalceal Arthrodesis

Brief summary

The purpose of this study is to review the use of surgeon applied liposomal release anesthetic (Exparel) for post operative analgesia. Hypothesis: Surgeon applied use of liposomal related anesthetic provides excellent post operative analgesia. Immediated and 72 hour narcotic use will be significantly impacted by the use of this modality.

Interventions

DRUGExparel

Sponsors

Pacira Pharmaceuticals, Inc
CollaboratorINDUSTRY
OrthoCarolina Research Institute, Inc.
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Any patient scheduled for ankle arthrodesis, a tibiotalocalcaneal arthrodesis, hindfoot arthrodesis including subtalar, double, triple, or isolated talonavicular arthrodesis * Patients over the age of 18 * The subject is psychosocially, mentally, and physically able to understand and comply with the requirements of the study

Exclusion criteria

* \< 18 years of age * Patients with a history of infection * Patients diagnosed with neuropathy or any form of numbness or loss of feeling in the arms or legs due to damaged nerves * Patients having surgery on both feet at the same time * Patients having any other different type of foot and ankle surgery

Design outcomes

Primary

MeasureTime frameDescription
Amount of Narcotic UseSurgery to post operative day 3Total morphine milligram equivalence dosing of all narcotic pain medications administered between the surgery and the third post-operative day.

Secondary

MeasureTime frameDescription
Visual Analog Scale of Pain (0-10)Post anesthesia care unit admission to post operative day 3Visual Analog Scale (VAS) of pain (0-10); with 10 indicating the greatest amount of pain. Post anesthesia care unit admission, post anesthesia care unit discharge, day of surgery, post operative day 1, post operative day 2, post operative day 3
Anti-emetic UseAfter surgery through discharge from hospital, usually 72 hours after surgery (on post operative day 3)Anti-emetic use (as a binary yes/no) between the admission in the post anesthesia care unit through hospital discharge (i.e. if a patient took an anti-emetic at any point duration the time frame the patient was a yes; if the patient did not take an anti-emetic during the time frame the patient was a no).
Patient Satisfaction Questionnaire Regarding Post Surgical Pain ReliefMeasured at hospital discharge (on post operative day 3)Measured at hospital discharge (on post operative day 3). Measured on a scale of 1-5, with 5 being the most satisfaction
Number of Patients With Post-operative ComplicationsAfter surgery to the first scheduled clinic visit, usually 14 days after surgeryAny complications occurring between the day of surgery and the first scheduled appointment at our clinic after the surgery.

Countries

United States

Participant flow

Participants by arm

ArmCount
Exparel
Patients will receive a single shot popliteal block (standard of care) and then undergo their standardized procedure. Patients will then receive 20cc Exparel and 10cc of normal saline at the conclusion of the case.
28
Total28

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyLost to Follow-up3
Overall StudyPhysician Decision4
Overall StudyWithdrawal by Subject1

Baseline characteristics

CharacteristicExparel
Age, Continuous55.6 years
Race and Ethnicity Not Collected— Participants
Region of Enrollment
United States
28 participants
Sex: Female, Male
Female
18 Participants
Sex: Female, Male
Male
10 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 36
other
Total, other adverse events
1 / 36
serious
Total, serious adverse events
1 / 36

Outcome results

Primary

Amount of Narcotic Use

Total morphine milligram equivalence dosing of all narcotic pain medications administered between the surgery and the third post-operative day.

Time frame: Surgery to post operative day 3

ArmMeasureValue (MEAN)
ExparelAmount of Narcotic Use236.68 mg
Secondary

Anti-emetic Use

Anti-emetic use (as a binary yes/no) between the admission in the post anesthesia care unit through hospital discharge (i.e. if a patient took an anti-emetic at any point duration the time frame the patient was a yes; if the patient did not take an anti-emetic during the time frame the patient was a no).

Time frame: After surgery through discharge from hospital, usually 72 hours after surgery (on post operative day 3)

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
ExparelAnti-emetic UseNo19 Participants
ExparelAnti-emetic UseYes9 Participants
Secondary

Number of Patients With Post-operative Complications

Any complications occurring between the day of surgery and the first scheduled appointment at our clinic after the surgery.

Time frame: After surgery to the first scheduled clinic visit, usually 14 days after surgery

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
ExparelNumber of Patients With Post-operative ComplicationsNo27 Participants
ExparelNumber of Patients With Post-operative ComplicationsYes1 Participants
Secondary

Patient Satisfaction Questionnaire Regarding Post Surgical Pain Relief

Measured at hospital discharge (on post operative day 3). Measured on a scale of 1-5, with 5 being the most satisfaction

Time frame: Measured at hospital discharge (on post operative day 3)

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
ExparelPatient Satisfaction Questionnaire Regarding Post Surgical Pain Relief13 Participants
ExparelPatient Satisfaction Questionnaire Regarding Post Surgical Pain Relief23 Participants
ExparelPatient Satisfaction Questionnaire Regarding Post Surgical Pain Relief34 Participants
ExparelPatient Satisfaction Questionnaire Regarding Post Surgical Pain Relief46 Participants
ExparelPatient Satisfaction Questionnaire Regarding Post Surgical Pain Relief512 Participants
Secondary

Visual Analog Scale of Pain (0-10)

Visual Analog Scale (VAS) of pain (0-10); with 10 indicating the greatest amount of pain. Post anesthesia care unit admission, post anesthesia care unit discharge, day of surgery, post operative day 1, post operative day 2, post operative day 3

Time frame: Post anesthesia care unit admission to post operative day 3

ArmMeasureGroupValue (MEAN)
ExparelVisual Analog Scale of Pain (0-10)Post anesthesia care unit admission0.96 units on a scale
ExparelVisual Analog Scale of Pain (0-10)Post anesthesia care unit discharge0.86 units on a scale
ExparelVisual Analog Scale of Pain (0-10)Day of Surgery2.36 units on a scale
ExparelVisual Analog Scale of Pain (0-10)Post-Operative Day 15.04 units on a scale
ExparelVisual Analog Scale of Pain (0-10)Post-operative Day 23.82 units on a scale
ExparelVisual Analog Scale of Pain (0-10)Post-operative Day 34.29 units on a scale

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026